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Abstract
Background: Osteogenesis imperfecta (OI) is a rare primarily autosomal dominant condition in which the
connective tissues of bones, ligaments and sclerae do not form properly. Typically, mutations in COL1A1 and
COL1A2 genes lead to the defective formation or quantity of type I collagen, the principle matrix in these tissues.
Molecular genetic studies have now elucidated multiple genetic subtypes of the disorder but little literature exists
on the risk of retinal tears and detachments in OI.
Case presentation: We report the first case of a child with a rare recessive type of OI, subtype VIII, resulting from a
P3H1 (also known as LEPRE1) gene mutation presenting with bilateral giant retinal tears and the surgical challenges
encountered in performing retinal detachment repair due to scleral thinning. The P3H1 gene encodes for prolyl 3-
hydroxylase 1 which is involved in the post-translational modification of not only collagen type I but also types II and V
which when mutated may result in pathological posterior vitreous detachment (PVD) and giant retinal tear detachments.
Conclusions: Genetic analyses are increasingly important in such cases and may guide patient monitoring and potential
prophylactic treatment, known to significantly reduce the probability of giant retinal tear detachments in other high-risk
collagenopathies such as Stickler Syndrome Type I.
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Background
Osteogenesis imperfecta (OI) is a rare inherited condi-
tion whereby the connective tissues of bones, ligaments
and sclerae do not form properly leading to structural
malformations due to the defective formation or quan-
tity of type I collagen. Phenotypically, OI patients exhibit
a range of morbidity from a mild predisposition to bone
fractures to extreme bone fragility, which can be fatal in
the perinatal period. The prominent ophthalmic feature
of OI is ‘blue sclera’ representing scleral thinning. [1, 2].
Epidemiological and genetic studies have elucidated
multiple OI subtypes demonstrating the long suspected
genetic heterogeneity of OI [3]. Currently, OI diagnosis
is carried out by evaluating the clinical presentation,
family history, radiographic findings and laboratory in-
vestigations (molecular genetic testing or biochemical
analysis of type I collagen). There are now over 15
known genetically and largely clinically distinct OI
subtypes. The genes involved code for type I collagen, or
factors involved in its processing, secretion and post-
translational modification. Other genes causing OI affect
the development or function of bone forming cells [4–6].
Previous studies describing retinal detachment (RD) in
OI have not focused on the OI subtype nor underlying
genetics, concentrating instead on the surgical chal-
lenges of RD repair principally due to thin sclerae, in-
cluding the increased risk of scleral rupture, choroidal
haemorrhage, vitreous haemorrhage and further iatro-
genic RD. External approaches to RD repair in OI have
been achieved via application of a sutureless scleral
buckle with tissue adhesive, although this technique
poses a possible risk of band dislodgement and migra-
tion [7], and application of an encircling band via su-
tures applied directly to muscle insertions, though this
required premature buckle removal due to a recurrent
conjunctival gape over the buckle site [8]. In another re-
port, RD repairs of 4 eyes in 3 patients included demar-
cation laser photocoagulation alone in a macula-sparing
RD, vitrectomy and gas requiring increased infusion
pressure to maintain globe stability and in another case
* Correspondence: paolo.scollo@cantab.net
1Vitreoretinal Service, Addenbrooke’s Hospital, Cambridge University NHS
Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK
Full list of author information is available at the end of the article
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Scollo et al. BMC Medical Genetics  (2018) 19:8 
DOI 10.1186/s12881-018-0521-0
equatorial scleral buckling which was abandoned due to
scleral perforation requiring conversion to vitrectomy
[9]. Elsewhere, internal tamponade for RD repair in OI
has been achieved via pneumatic retinopexy with suc-
cessful suture closure of sclerostomies and more recently
via 25-gauge sutureless vitrectomy [10–12].
Case presentation
A 9 year-old boy with severe OI and previous history of
multiple fractures, small stature and associated skull de-
formities presented with loss of vision in his right eye of
unknown duration. The patient exhibited a low degree
of myopia (RE −1.50/−3.00 × 180; LE −1.00/−3.50 × 173)
and the anterior sclera was abnormally thin. Posterior
segment examination revealed a right macula-off retinal
detachment associated with a giant retinal tear (GRT)
and C3 proliferative vitreoretinopathy (PVR).
Genetic analysis was performed by an NHS England
molecular genetics service, when the child was 2 years
old. At that time (2008) no potentially causative DNA
change was found in COL1A1 or COL1A2, and so gen-
etic analysis targeted regions of the CRTAP and P3H1
(previously named LEPRE1) genes, which had only re-
cently been shown to cause recessive osteogenesis
imperfecta [13]. This revealed a homozygous change
c.1914 + 1G > A (NM_001243246.1) splice site mutation
in intron 13 of P3H1 gene with parents being first cous-
ins and heterozygous for same mutation. The same
change has also been reported by Pepin et al. [14] in a
case of osteogenesis imperfecta with compound hetero-
zygous mutations of P3H1. Although they were unable
to determine the effect of this particular c.1914 + 1G > A
mutation on the mRNA, in the majority of the other
cases of P3H1 mutations that they studied, mRNA in-
stability was the outcome [14].
Examination under anaesthetic (EUA) showed a right
GRT from 6 to 10 o’clock associated with a macula-off
detachment and inferior epiretinal and subretinal fibrosis
(Fig. 1). EUA of the fellow eye revealed a further 180-
degree GRT from 1 to 7 o’clock associated with a
macula-sparing retinal detachment. A right 360-degree
peritomy for placement of bridle sutures revealed a
sclera that was more grey than blue in hue but very thin
(see Fig. 2). Right RD repair was performed via single-
port pars plana vitrectomy (PPV), tamponade with sili-
cone oil and cryoretinopexy extended to 360 degrees.
The single sclerostomy and conjunctiva were success-
fully closed with polyglactin absorbable sutures.
Surgery for the left eye consisted of PPV and fluid/per-
fluorocarbon liquid (PFCL) exchange to unroll the pos-
terior flap of the GRT, followed by direct PFCL-silicone
oil exchange. Retinopexy was again applied to both the
GRT and completed through 360 degrees.
Persistent antero-posterior PVR meant further right
eye surgery was required, involving a 360-degree buckle,
a silicone oil top-up and further retinopexy to seal a leak
in the lower horn of the GRT. Scleral fixation sutures
were not possible for the buckling procedure, which was
completed with two 5/0 vicryl sutures tethering the an-
terior edge of the buckle to the medial and lateral recti
to prevent posterior buckle migration with end to end
shortening and suturing of the 360-degree explant.
Retinal stability was achieved in both eyes but a chronic
inferior RD in context of extensive PVR remains under
silicone oil in the right eye. Visual acuity with silicone
oil in situ at time of writing is RE 6/36, LE 6/12.
Discussion and conclusions
Some suggest that decreased ocular rigidity in OI could
increase tractional forces on the peripheral retina placing
greater stress upon the vitreoretinal-retinal pigment epi-
thelium relationship, possibly increasing the risk of RD
[10]. Ocular rigidity is significantly reduced in OI when
Fig. 1 Right retinal detachment with inferior
proliferative vitreoretinopathy
Fig. 2 Exposed sclera following 360 degree peritomy demonstrating
blue/grey hue due to scleral thinning
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compared with controls but this fails to explain the
causal relationship with pathological PVD leading to
GRTs. Madigan et al. [10] speculate that if collagen type
I is affected in OI, collagen type II could also be affected
by some unknown mechanism. To our knowledge, no
subsequent studies have investigated the underlying gen-
etic mechanisms that result in OI patients having a pre-
dilection for pathological PVD leading to RD.
The P3H1 gene, abnormal in OI subtype VIII, encodes
for prolyl 3-hydroxylase 1 which is involved in catalysing
the post-translational modification of not only collagen
type I found in the sclera but also collagen types II and V
which are expressed in the mature vitreous matrix [15].
We hypothesise that the case described above raises the
possibility of a common pathway shared with other
vitreoretinopathies affecting collagen sub-types expressed
in the vitreous, including COL2A1 and COL11A1 gene
mutations that cause defective type II and XI vitreous
collagen in Stickler Syndrome, also associated with a high
risk of pathological PVD and GRT detachment [16].
Earlier studies describe type VIII OI as a phenotype
typically expressing normal sclerae [15], however, the an-
terior sclerae in our patient was found to be abnormally
thin. There is a high risk of scleral perforation with
scleral buckling techniques in OI even when sutures are
placed superficially and as found in this case, as well as
in a previous report, a lack of scleral blueness may be
misleading [9]. Although successful approaches to RD
repair in OI can be achieved via sutureless micro-
incision vitrectomy, an approach with potentially shorter
operating times, reduced trauma, astigmatism and pa-
tient discomfort [12], the potential greater risk of wound
leakage, hypotony and intraocular infection in patients
with very thin sclera must be considered.
RD can be devastating to vision and in OI in particular
may cause further morbidity due to a greater risk of bone
fractures. In OI, genetic analysis may potentially guide
ophthalmic monitoring programmes and where appropri-
ate prophylactic treatment which has been shown to sig-
nificantly reduce the probability of RD in other high-risk
genetic conditions such as Stickler Syndrome Type I [16].
Further research is required to elucidate the molecular
mechanisms of pathological PVD in such patients.
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